Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis

References

• Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001; 58:244 - 58; http://dx.doi.org/10.1007/PL00000852; PMID: 11289306
   PubMed Web of Science ®Google Scholar
• Rider JE, Hacker A, Mackintosh CA, Pegg AE, Woster PM, Casero RA Jr.. Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide. Amino Acids 2007; 33:231 - 40; http://dx.doi.org/10.1007/s00726-007-0513-4; PMID: 17396215
   PubMed Web of Science ®Google Scholar
• Igarashi K, Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol 2010; 42:39 - 51; http://dx.doi.org/10.1016/j.biocel.2009.07.009; PMID: 19643201
   PubMed Web of Science ®Google Scholar
• Childs AC, Mehta DJ, Gerner EW. Polyamine-dependent gene expression. Cell Mol Life Sci 2003; 60:1394 - 406; http://dx.doi.org/10.1007/s00018-003-2332-4; PMID: 12943227
   PubMed Web of Science ®Google Scholar
• Wang JY. Polyamines and mRNA stability in regulation of intestinal mucosal growth. Amino Acids 2007; 33:241 - 52; http://dx.doi.org/10.1007/s00726-007-0518-z; PMID: 17404803
   PubMed Web of Science ®Google Scholar
• Gerner EW, Meyskens FL Jr.. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004; 4:781 - 92; http://dx.doi.org/10.1038/nrc1454; PMID: 15510159
   PubMed Web of Science ®Google Scholar
• Casero RA Jr., Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 2007; 6:373 - 90; http://dx.doi.org/10.1038/nrd2243; PMID: 17464296
   PubMed Web of Science ®Google Scholar
• Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003; 376:1 - 14; http://dx.doi.org/10.1042/BJ20031327; PMID: 13678416
   PubMed Web of Science ®Google Scholar
• Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life 2009; 61:880 - 94; http://dx.doi.org/10.1002/iub.230; PMID: 19603518
   PubMed Web of Science ®Google Scholar
• Nishimura K, Nakatsu F, Kashiwagi K, Ohno H, Saito T, Igarashi K. Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells 2002; 7:41 - 7; http://dx.doi.org/10.1046/j.1356-9597.2001.00494.x; PMID: 11856372
   PubMed Web of Science ®Google Scholar
• Pendeville H, Carpino N, Marine JC, Takahashi Y, Muller M, Martial JA, et al. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 2001; 21:6549 - 58; http://dx.doi.org/10.1128/MCB.21.19.6549-6558.2001; PMID: 11533243
   PubMed Web of Science ®Google Scholar
• Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem 2006; 281:14529 - 32; http://dx.doi.org/10.1074/jbc.R500031200; PMID: 16459331
   PubMed Web of Science ®Google Scholar
• Pegg AE. S-Adenosylmethionine decarboxylase. Essays Biochem 2009; 46:25 - 45; http://dx.doi.org/10.1042/bse0460003; PMID: 20095968
   PubMed Web of Science ®Google Scholar
• Ikeguchi Y, Bewley MC, Pegg AE. Aminopropyltransferases: function, structure and genetics. J Biochem 2006; 139:1 - 9; http://dx.doi.org/10.1093/jb/mvj019; PMID: 16428313
   PubMed Web of Science ®Google Scholar
• Coffino P. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2001; 2:188 - 94; http://dx.doi.org/10.1038/35056508; PMID: 11265248
   PubMed Web of Science ®Google Scholar
• Kahana C. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. Essays Biochem 2009; 46:47 - 61; http://dx.doi.org/10.1042/bse0460004; PMID: 20095969
   PubMed Web of Science ®Google Scholar
• Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J 2009; 421:323 - 38; http://dx.doi.org/10.1042/BJ20090598; PMID: 19589128
   PubMed Web of Science ®Google Scholar
• Feith DJ. Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolism. Methods Mol Biol 2011; 720:129 - 41; http://dx.doi.org/10.1007/978-1-61779-034-8_7; PMID: 21318870
   PubMedGoogle Scholar
• Jänne J, Alhonen L, Pietilä M, Keinänen TA. Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem 2004; 271:877 - 94; http://dx.doi.org/10.1111/j.1432-1033.2004.04009.x; PMID: 15009201
   PubMedGoogle Scholar
• Jänne J, Alhonen L, Pietilä M, Keinänen TA, Uimari A, Hyvönen MT, et al. Genetic manipulation of polyamine catabolism in rodents. J Biochem 2006; 139:155 - 60; http://dx.doi.org/10.1093/jb/mvj035; PMID: 16452302
   PubMed Web of Science ®Google Scholar
• Abel EL, Angel JM, Kiguchi K, DiGiovanni J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 2009; 4:1350 - 62; http://dx.doi.org/10.1038/nprot.2009.120; PMID: 19713956
   PubMed Web of Science ®Google Scholar
• O’Brien TG. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 1976; 36:2644 - 53; PMID: 1277170
   PubMed Web of Science ®Google Scholar
• Scalabrino G, Ferioli ME. Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy. Cancer Detect Prev 1985; 8:11 - 6; PMID: 4064029
   PubMedGoogle Scholar
• Gilmour SK, Verma AK, Madara T, O’Brien TG. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res 1987; 47:1221 - 5; PMID: 3815331
   PubMed Web of Science ®Google Scholar
• Koza RA, Megosh LC, Palmieri M, O’Brien TG. Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis 1991; 12:1619 - 25; http://dx.doi.org/10.1093/carcin/12.9.1619; PMID: 1909938
   PubMed Web of Science ®Google Scholar
• Pegg AE, Feith DJ. Polyamines and neoplastic growth. Biochem Soc Trans 2007; 35:295 - 9; http://dx.doi.org/10.1042/BST0350295; PMID: 17371264
   PubMed Web of Science ®Google Scholar
• Gilmour SK. Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 2007; 224:249 - 56; http://dx.doi.org/10.1016/j.taap.2006.11.023; PMID: 17234230
   PubMed Web of Science ®Google Scholar
• Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247:322 - 4; http://dx.doi.org/10.1126/science.2296722; PMID: 2296722
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Hamilton SR, Hylind LM, Yang VW, Tamez P, Casero RA Jr.. Ornithine decarboxylase and polyamines in familial adenomatous polyposis. Cancer Res 1997; 57:199 - 201; PMID: 9000553
   PubMed Web of Science ®Google Scholar
• Shoemaker AR, Gould KA, Luongo C, Moser AR, Dove WF. Studies of neoplasia in the Min mouse. Biochim Biophys Acta 1997; 1332:F25 - 48; PMID: 9141462
   PubMed Web of Science ®Google Scholar
• Berger FG, Kramer DL, Porter CW. Polyamine metabolism and tumorigenesis in the Apc(Min/+) mouse. Biochem Soc Trans 2007; 35:336 - 9; http://dx.doi.org/10.1042/BST0350336; PMID: 17371273
   PubMed Web of Science ®Google Scholar
• Gerner EW, Meyskens FL Jr.. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res 2009; 15:758 - 61; http://dx.doi.org/10.1158/1078-0432.CCR-08-2235; PMID: 19188144
   PubMed Web of Science ®Google Scholar
• Ignatenko NA, Gerner EW, Besselsen DG. Defining the role of polyamines in colon carcinogenesis using mouse models. J Carcinog 2011; 10:10; http://dx.doi.org/10.4103/1477-3163.79673; PMID: 21712957
   PubMedGoogle Scholar
• Fultz KE, Gerner EW. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol Carcinog 2002; 34:10 - 8; http://dx.doi.org/10.1002/mc.10043; PMID: 12112318
   PubMed Web of Science ®Google Scholar
• Erdman SH, Ignatenko NA, Powell MB, Blohm-Mangone KA, Holubec H, Guillén-Rodriguez JM, et al. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 1999; 20:1709 - 13; http://dx.doi.org/10.1093/carcin/20.9.1709; PMID: 10469614
   PubMed Web of Science ®Google Scholar
• Ignatenko NA, Besselsen DG, Roy UK, Stringer DE, Blohm-Mangone KA, Padilla-Torres JL, et al. Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis. Nutr Cancer 2006; 56:172 - 81; http://dx.doi.org/10.1207/s15327914nc5602_8; PMID: 17474863
   PubMed Web of Science ®Google Scholar
• Ignatenko NA, Besselsen DG, Stringer DE, Blohm-Mangone KA, Cui H, Gerner EW. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis. Nutr Cancer 2008; 60:Suppl 1 30 - 5; http://dx.doi.org/10.1080/01635580802401317; PMID: 19003578
   PubMed Web of Science ®Google Scholar
• Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, et al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res 2000; 60:1864 - 70; PMID: 10766173
   PubMed Web of Science ®Google Scholar
• Tucker JM, Murphy JT, Kisiel N, Diegelman P, Barbour KW, Davis C, et al. Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Cancer Res 2005; 65:5390 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-0229; PMID: 15958588
   PubMed Web of Science ®Google Scholar
• Bailey HH, Kim K, Verma AK, Sielaff K, Larson PO, Snow S, et al. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of alpha-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila) 2010; 3:35 - 47; http://dx.doi.org/10.1158/1940-6207.CAPR-09-0096; PMID: 20051371
   PubMed Web of Science ®Google Scholar
• Meyskens FL Jr., McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. [Phila Pa] Cancer Prev Res (Phila) 2008; 1:32 - 8; http://dx.doi.org/10.1158/1940-6207.CAPR-08-0042; PMID: 18841250
   PubMed Web of Science ®Google Scholar
• Ikeguchi Y, Wang X, McCloskey DE, Coleman CS, Nelson P, Hu G, et al. Characterization of transgenic mice with widespread overexpression of spermine synthase. Biochem J 2004; 381:701 - 7; http://dx.doi.org/10.1042/BJ20040419; PMID: 15104536
   PubMed Web of Science ®Google Scholar
• Feith DJ, Shantz LM, Shoop PL, Keefer KA, Prakashagowda C, Pegg AE. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds. Mol Carcinog 2007; 46:453 - 65; http://dx.doi.org/10.1002/mc.20294; PMID: 17219416
   PubMed Web of Science ®Google Scholar
• Pegg AE, Wang X, Schwartz CE, McCloskey DE. Spermine synthase activity affects the content of decarboxylated S-adenosylmethionine. Biochem J 2011; 433:139 - 44; http://dx.doi.org/10.1042/BJ20101228; PMID: 20950271
   PubMed Web of Science ®Google Scholar
• Wang X, Feith DJ, Welsh P, Coleman CS, Lopez C, Woster PM, et al. Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis. Carcinogenesis 2007; 28:2404 - 11; http://dx.doi.org/10.1093/carcin/bgm162; PMID: 17675337
   PubMed Web of Science ®Google Scholar
• Coleman CS, Pegg AE, Megosh LC, Guo Y, Sawicki JA, O’Brien TG. Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. Carcinogenesis 2002; 23:359 - 64; http://dx.doi.org/10.1093/carcin/23.2.359; PMID: 11872645
   PubMed Web of Science ®Google Scholar
• Guo Y, Cleveland JL, O’Brien TG. Haploinsufficiency for odc modifies mouse skin tumor susceptibility. Cancer Res 2005; 65:1146 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-04-3244; PMID: 15734996
   PubMed Web of Science ®Google Scholar
• Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, et al. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 2005; 7:433 - 44; http://dx.doi.org/10.1016/j.ccr.2005.03.036; PMID: 15894264
   PubMed Web of Science ®Google Scholar
• Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, et al. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice. J Biol Chem 2004; 279:40076 - 83; http://dx.doi.org/10.1074/jbc.M406002200; PMID: 15252047
   PubMed Web of Science ®Google Scholar
• Wang X, Ikeguchi Y, McCloskey DE, Nelson P, Pegg AE. Spermine synthesis is required for normal viability, growth, and fertility in the mouse. J Biol Chem 2004; 279:51370 - 5; http://dx.doi.org/10.1074/jbc.M410471200; PMID: 15459188
   PubMed Web of Science ®Google Scholar
• Wang X, Levic S, Gratton MA, Doyle KJ, Yamoah EN, Pegg AE. Spermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine. J Biol Chem 2009; 284:930 - 7; http://dx.doi.org/10.1074/jbc.M807758200; PMID: 19001365
   PubMed Web of Science ®Google Scholar
• Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr Drug Targets 2003; 4:537 - 64; http://dx.doi.org/10.2174/1389450033490885; PMID: 14535654
   PubMed Web of Science ®Google Scholar
• Ikeguchi Y, Mackintosh CA, McCloskey DE, Pegg AE. Effect of spermine synthase on the sensitivity of cells to anti-tumour agents. Biochem J 2003; 373:885 - 92; http://dx.doi.org/10.1042/BJ20030246; PMID: 12737625
   PubMed Web of Science ®Google Scholar
• Astrup EG, Paulsen JE. Changes in epidermal polyamine biosynthesis and specific activity of DNA following a single application of 12-O-tetradecanoyl-phorbol-13-acetate to hairless mouse skin. Carcinogenesis 1981; 2:545 - 51; http://dx.doi.org/10.1093/carcin/2.6.545; PMID: 7273334
   PubMed Web of Science ®Google Scholar
• Feith DJ, Origanti S, Shoop PL, Sass-Kuhn S, Shantz LM. Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis. Carcinogenesis 2006; 27:1090 - 8; http://dx.doi.org/10.1093/carcin/bgi343; PMID: 16400186
   PubMed Web of Science ®Google Scholar
• Feith DJ, Shantz LM, Pegg AE. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res 2001; 61:6073 - 81; PMID: 11507056
   PubMed Web of Science ®Google Scholar
• Meyskens FL Jr., Emerson SS, Pelot D, Meshkinpour H, Shassetz LR, Einspahr J, et al. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 1994; 86:1122 - 30; http://dx.doi.org/10.1093/jnci/86.15.1122; PMID: 8028034
   PubMed Web of Science ®Google Scholar
• Shi C, Welsh PA, Sass-Kuhn S, Wang X, McCloskey DE, Pegg AE, et al. Characterization of transgenic mice with overexpression of spermidine synthase. Amino Acids 2011; http://dx.doi.org/10.1007/s00726-011-1028-6; PMID: 21809077
   PubMed Web of Science ®Google Scholar
• Riggs PK, Angel JM, Abel EL, DiGiovanni J. Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion. Mol Carcinog 2005; 44:122 - 36; http://dx.doi.org/10.1002/mc.20127; PMID: 16044405
   PubMed Web of Science ®Google Scholar
• Xiao L, Cui YH, Rao JN, Zou T, Liu L, Smith A, et al. Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines. Mol Biol Cell 2011; 22:3055 - 69; http://dx.doi.org/10.1091/mbc.E11-01-0069; PMID: 21737690
   PubMed Web of Science ®Google Scholar
• Hayes CS, Defeo K, Dang H, Trempus CS, Morris RJ, Gilmour SK. A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development. Carcinogenesis 2011; 32:1340 - 8; http://dx.doi.org/10.1093/carcin/bgr129; PMID: 21730362
   PubMed Web of Science ®Google Scholar
• Keough MP, Hayes CS, DeFeo K, Gilmour SK. Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity. J Invest Dermatol 2011; 131:158 - 66; http://dx.doi.org/10.1038/jid.2010.263; PMID: 20844550
   PubMed Web of Science ®Google Scholar
• Mackintosh CA, Pegg AE. Effect of spermine synthase deficiency on polyamine biosynthesis and content in mice and embryonic fibroblasts, and the sensitivity of fibroblasts to 1,3-bis-(2-chloroethyl)-N-nitrosourea. Biochem J 2000; 351:439 - 47; http://dx.doi.org/10.1042/0264-6021:3510439; PMID: 11023830
   PubMed Web of Science ®Google Scholar
• Nisenberg O, Pegg AE, Welsh PA, Keefer K, Shantz LM. Overproduction of cardiac S-adenosylmethionine decarboxylase in transgenic mice. Biochem J 2006; 393:295 - 302; http://dx.doi.org/10.1042/BJ20051196; PMID: 16153183
   PubMed Web of Science ®Google Scholar
• Becerra-Solano LE, Butler J, Castañeda-Cisneros G, McCloskey DE, Wang X, Pegg AE, et al. A missense mutation, p.V132G, in the X-linked spermine synthase gene (SMS) causes Snyder-Robinson syndrome. Am J Med Genet A 2009; 149A:328 - 35; http://dx.doi.org/10.1002/ajmg.a.32641; PMID: 19206178
   PubMed Web of Science ®Google Scholar
• Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75:631 - 9; http://dx.doi.org/10.1016/0092-8674(93)90484-8; PMID: 8242739
   PubMed Web of Science ®Google Scholar